市场调查报告书
商品编码
1292431
按产品类型(传统超声、自动超声)、按最终用途(医院、诊断实验室)分類的乳房超声市场规模 - 全球预测至2032年Breast Ultrasound Market Size By Product Type (Conventional Ultrasound, Automated Ultrasound), By End-use (Hospitals, Diagnostics Laboratories) - Global Forecast to 2032 |
全球自动乳腺超声系统(ABUS)的市场规模将在2032年之前呈指数式增长。美国对乳腺超声和数字乳腺断层扫描的有利报销政策正在为行业增长铺平道路。根据《平价医疗法案》,美国癌症协会癌症行动网络为乳腺癌筛查提供全面的保障。它还鼓励各州通过州医疗补助计划增加对低收入群体的医疗保障。
此外,乳房X光检查在分析致密乳腺组织方面的能力有限,这进一步增加了自动乳腺超声系统的采用。ABUS提供了更清晰、更详细的图像,加强了对癌性病变的可视化和特征分析。这导致准确和及时的诊断,并通过检测可能无法通过乳房X光检查发现的癌症,帮助减少假阴性。
整个自动乳腺超声系统市场根据产品、终端用途和地区进行细分。
基于产品,从2023年到2032年,自动乳腺容积扫描仪(ABVS)的市场份额将以超过15%的年复合增长率增长。最近ABVS的进步为细分市场的扩张提供了有利可图的机会。一些ABVS系统现在结合了AR可视化技术,允许放射科医生在虚拟环境中查看并与3D图像互动。AR技术提供了一个更直观和身临其境的体验,增强了放射科医生解释图像的能力,以获得更好的病人结果。
基于终端用途,诊断成像中心部分的自动乳腺超声系统市场价值将在2023-2032年积累丰厚的收益。印度和中国等发展中经济体不断增长的医疗支出增加了诊断成像中心的数量,为该领域的增长创造了明显的推动力。此外,这些设施拥有高可用性的专业诊断工具,这使它们成为首选的医疗保健提供者。
这些中心还提供一系列的成像模式,允许采用多模式的方法检测乳腺癌。结合多种成像技术,如乳房X光检查、超声波和核磁共振,提高了检测的准确性和敏感性,进一步推动了产品需求。
在区域方面,欧洲自动乳腺超声系统市场到2032年将价值12亿美元。由于越来越多的人采用久坐的生活方式和不适当的饮食习惯,乳腺癌的发病率不断上升,增加了该地区的产品接受度。此外,该地区的行业参与者,如Koninklijke Philips N.V.和其他公司,正在投资于产品创新,以扩大他们的客户群,因此,为区域ABUS行业创造了一个有利的增长前景。
Global Automated Breast Ultrasound Systems (ABUS) Market size will expand exponentially through 2032. Favorable reimbursement policies for breast ultrasound and digital breast tomosynthesis in the U.S. is paving the path for industry growth. Under the Affordable Care Act, the American Cancer Society Cancer Action Network offers comprehensive coverage for breast cancer screening. It also encourages states to increase their healthcare coverage for people from low-income groups through the state Medicaid programs.
Moreover, the limited capability of mammography in analyzing dense breast tissues has further increased the adoption of automated breast ultrasound systems. ABUS provides clearer and more detailed images, enhancing the visualization and characterization of cancerous lesions. This results in accurate and timely diagnosis and helps reduce false negatives by detecting cancers that may not have detected through mammography.
The overall automated breast ultrasound systems market is segmented based on product, end-use, and region.
Based on the product, the automated breast volume scanner (ABVS) market share will grow at more than 15% CAGR from 2023 to 2032. Recent advancements in ABVS are presenting lucrative opportunities for segment expansion. Some ABVS systems now incorporate AR visualization technology, allowing radiologists to view and interact with the 3D images in a virtual environment. AR technology provides a more intuitive and immersive experience, enhancing the radiologist's ability to interpret the images for better patient outcomes.
Based on end-use, automated breast ultrasound systems market value from the diagnostic imaging centers segment will amass lucrative gains over 2023-2032. Growing healthcare expenditure in developing economies such as India and China has increased the number of diagnostic imaging centers, creating a notable impetus for segment growth. Moreover, these facilities have high availability of specialized diagnostic tools, which has made them a preferred healthcare provider.
These centers also offer a range of imaging modalities, allowing for a multi-modal approach to breast cancer detection. Combining multiple imaging techniques, such as mammography, ultrasound, and MRI, enhances the accuracy and sensitivity of detection, further driving product demand.
On the regional front, Europe automated breast ultrasound systems market will be worth USD 1.2 billion by 2032. Rising prevalence of breast cancer attributed to the growing adoption of a sedentary lifestyle and inadequate eating habits has increased product uptake in the region. Moreover, industry players in the region, such as Koninklijke Philips N.V. and others, are investing in product innovations to broaden their customer base, thus, creating a favorable growth outlook for the regional ABUS industry.